Literature DB >> 19389318

HIV infection in the United States household population aged 18-49 years: results from 1999-2006.

Geraldine M McQuillan1, Deanna Kruszon-Moran.   

Abstract

Data from the National Health and Nutrition Examination Surveys (NHANES). The prevalence of HIV infection among adults aged 18-49 years residing in households in the United States was 0.47% for the period 1999-2006. Men were more likely to be HIV positive than women. Race/ethnic disparities in HIV infection were also seen. Non-Hispanic blacks were more likely to be HIV positive than all other race/ethnic groups. Infection with HSV-2 was significantly associated with HIV infection among the total population aged 18-49 years and especially so among the non-His-panic black population. In 1999-2006, nearly one-quarter of HIV-positive individuals but only 1% of the HIV-negative individuals aged 18-49 years had low CD4 counts (a marker of decreased immune function). Approximately one-third of HIV-positive persons had healthy immune systems as compared with 90% among those HIV negative. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Year:  2008        PMID: 19389318

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  10 in total

1.  Management of HIV-1 infection in adults.

Authors:  Thien Huong Nguyen
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-01

2.  HIV risk behaviors in the U.S. transgender population: prevalence and predictors in a large internet sample.

Authors:  Jamie Feldman; Rebecca Swinburne Romine; Walter O Bockting
Journal:  J Homosex       Date:  2014

Review 3.  Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness.

Authors:  Ellen M Janssen; Emma E McGinty; Susan T Azrin; Denise Juliano-Bult; Gail L Daumit
Journal:  Gen Hosp Psychiatry       Date:  2015-03-14       Impact factor: 3.238

4.  How Qualitative Methods Contribute to Intervention Adaptation: An HIV Risk Reduction Example.

Authors:  Rochelle K Rosen; Caroline Kuo; Robyn L Gobin; Marlanea Peabody; Wendee Wechsberg; Caron Zlotnick; Jennifer E Johnson
Journal:  Qual Psychol       Date:  2017-04-24

5.  HIV Testing Among Men at Risk for Acquiring HIV Infection Before and After the 2006 CDC Recommendations.

Authors:  Candice K Kwan; Charles E Rose; John T Brooks; Gary Marks; Catlainn Sionean
Journal:  Public Health Rep       Date:  2016 Mar-Apr       Impact factor: 2.792

6.  Function, regulation, and transcriptional organization of the hemin utilization locus of Bartonella quintana.

Authors:  Nermi L Parrow; Jasmin Abbott; Amanda R Lockwood; James M Battisti; Michael F Minnick
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

7.  The Nutritional Status of HIV-Infected US Adults.

Authors:  Sowmyanarayanan V Thuppal; Shinyoung Jun; Alexandra Cowan; Regan L Bailey
Journal:  Curr Dev Nutr       Date:  2017-09-27

8.  Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT.

Authors:  Christen Vagts; Christian Ascoli; Dustin R Fraidenburg; Robert P Baughman; Yue Huang; Russell Edafetanure-Ibeh; Samreen Ahmed; Benjamin Levin; Yang Lu; David L Perkins; Patricia W Finn; Nadera J Sweiss
Journal:  Front Med (Lausanne)       Date:  2021-02-24

9.  Underutilization of HIV Testing Among Men with Incarceration Histories.

Authors:  Claire E Farel; Carol E Golin; Rebecca D Ochtera; David L Rosen; Marjorie Margolis; Wizdom Powell; David A Wohl
Journal:  AIDS Behav       Date:  2019-04

10.  Incarceration history relative to health, substance use, and violence in a sample of vulnerable South African women: implications for health services in criminal justice settings.

Authors:  Jennifer E Johnson; Tara Carney; Tracy Kline; Felicia A Browne; Wendee M Wechsberg
Journal:  Subst Abuse Rehabil       Date:  2012-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.